|
İçindekiler: Ginkgo Biloba & Bal 20 : 180 gr. bal + 20 gr. ginkgo biloba.
Ginkgo dünyadaki tarihi en eskiye dayanan ve en iyi tanınan ağaçlardan biridir. Gingko yaprağı özü, Çinli şifalı ot uzmanları tarafından 5.000 yıldan fazla bir süredir çok çeşitli rahatsızlıkların tedavisinde kullanılmıştır. Ginkgo Biloba özü günümüzde Avrupa’da hastalara en çok yazılan bitkisel ürün olup, ABD’de en sık kullanılan beşinci bitki ürünüdür.
Ginkgo Biloba özünde iki ana bileşen grubu bulunmaktadır: Ginkgo flavonglikozitler (quercetin, kaempferol ve isorhammetin) ve terpen laktonları (Bilobalid, Ginkgolid A, Ginkgolid B, Ginkgolid C). Bu ana bileşenler veya bileşen grupları ginkgo bilobanın iki temel özelliğinin arkasında yatan nedenlerdir. Sözkonusu iki temel özellik kanda pıhtı birikimini engelleme yeteneği (böylece beyin ve uçlarına daha fazla kan akışını sağlaması) ve güçlü antioksidan özelliğidir. (Bu özelliklerin beyin ve merkezi sinir sistemi üzerinde koruyucu etki yaptığı belirtilmiştir).
Kullanım Şekli: Sabahları kahvaltı öncesi 1 tatlı kaşığı alınması tavsiye edilir. Kullanım öncesi mutlaka tahta veya plastik bir kaşıkla karıştırılması gerekmektedir.
Referanslar
Ginkgo Biloba
1. Agnoli A, Fiorani P, Pistolese GR. Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of ginkgo-biloba. Minerva Med. 1973 Nov 7;64(79 Suppl):4166-73.
2. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Therapy 1998; 24:139-45.
3. al-Zuhair H, Abd el-Fattah A, el-Sayed MI. The effect of meclofenoxate with ginkgo biloba extract or zinc on lipid peroxide, some free radical scavengers and the cardiovascular system of aged rats. Pharmacol Res. 1998 Jul;38(1):65-72.
4. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000 Feb;71(2):621S-629S.
5. Deberdt W. Interaction between psychological and pharmacological treatment in cognitive impairment. Life Sci. 1994;55(25-26):2057-66.
6. Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil. 2000 May;81(5):668-78.
7. Fowler JS, Wang GJ, Volkow ND, Logan J, Franceschi D, Franceschi M, MacGregor R, Shea C, Garza V, Liu N, Ding YS. Evidence that gingko biloba extract does not inhibit MAO A andB in living human brain. Life Sci. 2000 Jan 21;66(9):PL141-6.
8. Garg RK, Nag D, Agrawal A. A double blind placebo controlled trial of ginkgo biloba extract in acute cerebral ischaemia. J Assoc Physicians India. 1995 Nov;43(11):760-3.
9. Gsell W, Reichert N, Youdim MB, Riederer P. Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro study. J Neural Transm Suppl. 1995;45:271-9.
10. Hannequin D, Thibert A, Vaschalde Y. Development of a model to study the anti-edema properties of Ginkgo biloba extract. Presse Med. 1986 Sep 25;15(31):1575-6.
11. Heiss WD. Pharmacologic modification of the circulation in the brain. Bull Schweiz Akad Med Wiss. 1980 Apr;36(1-3):183-207.
12. Heiss WD. Therapy of cerebral ischemia. Z Kardiol. 1987;76 Suppl 4:87-98.
13. Hemmer R, Tzavellas O. On cerebral effect of plant preparation from Ginkgo biloba. Arzneimittelforschung. 1967 Apr;17(4):491-3.
14. Hofferberth B. The effect of Ginkgo biloba extract on neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double-blind study against placebo. Arzneimittelforschung. 1989 Aug;39(8):918-22.
15. Hoyer S. Possibilities and limits of therapy of cognition disorders in the elderly. Z Gerontol Geriatr. 1995 Nov-Dec;28(6):457-62.
16. Itil TM, Eralp E, Ahmed I, Kunitz A, Itil KZ. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.Psychopharmacol Bull. 1998;34(3):391-7.
17. Ivaniv OP. The results of using different forms of a Ginkgo biloba extract (EGb 761) in the combined treatment of patients with circulatory encephalopathy. Lik Sprava. 1998 Dec;(8):123-8.
18. Khalsa DS. Integrated medicine and the prevention and reversal of memory loss. Altern Ther Health Med. 1998 Nov;4(6):38-43.
19. Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev. 1999 Jun;4(3):144-61.
20. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet. 1992 Nov 7;340(8828):1136-9.
21. Koltringer P, Eber O, Klima G, Rothlauer W, Wakonig P, Langsteger W, Lind P.Microcirculation in parenteral Ginkgo biloba extract therapy. Wien Klin Wochenschr. 1989 Mar 17;101(6):198-200.
22. Kunkel H. EEG profile of three different extractions of Ginkgo biloba. Neuropsychobiology. 1993;27(1):40-5.
23. Massoni G, Piovella C, Fratti L. Effects on microcirculation of Ginkgo-biloba in eld erly people. G Gerontol. 1972 May;20(5):444-50.
24. Perry EK, Pickering AT, Wang WW, Houghton P, Perry NS. Medicinal plants and Alzheimer's disease: Integrating ethnobotanical and contemporary scientific evidence. J Altern Complement Med. 1998 Winter;4(4):419-28.
25. Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J Pharm Pharmacol. 1999 May;51(5):527-34.
26. Pidoux B. Effects of Ginkgo biloba extract on functional brain activity. An assessment of clinical and experimental studies. Presse Med. 1986 Sep 25;15(31):1588-91.
27. Pitchumoni SS, Doraiswamy PM. Current status of antioxidant therapy for Alzheimer's Disease. J Am Geriatr Soc. 1998 Dec;46(12):1566-72.
28. Pospelova ML, Barnaulov OD. The antihypoxic and antioxidant action of medicinal plants as the basis for their use in destructive brain diseases. Fiziol Cheloveka. 2000 Jan-Feb;26(1):100-6.
29. Raabe A, Raabe M, Ihm P. Therapeutic follow-up using automatic perimetry in chronic cerebroretinal ischemia in elderly patients. Prospective double-blind study with graduated dose ginkgo biloba treatment. Klin Monatsbl Augenheilkd. 1991 Dec;199(6):432-8.
30. Racagni G, Brunello N, Paoletti R. Neuromediator changes during cerebral aging. The effect of Ginkgo biloba extract. Presse Med. 1986 Sep 25;15(31):1488-90.
31. Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Davignon J, Quirion R, Poirier J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic Biol Med. 1999 Sep;27(5-6):544-53.
32. Reisecker F. Therapy approaches in cerebral cognitive deficits--neuropsychiatric aspects. Wien Med Wochenschr. 1996;146(21-22):546-8.
33. Saponaro A. Modifications of the rheogram of cranial retinal vessels following administration of ginkgo-biloba. Minerva Med. 1973 Nov 7;64(79 Suppl):4194-8.
34. Sastre J, Pallardo FV, Garcia de la Asuncion J, Vina J. Mitochondria, oxidative stress and aging. Free Radic Res. 2000 Mar;32(3):189-98.
35. Semlitsch HV, Anderer P, Saletu B, Binder GA, Decker KA. Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment. Pharmacopsychiatry. 1995 Jul;28(4):134-42.
36. Spinnewyn B, Blavet N, Clostre F. Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils. Presse Med. 1986 Sep 25;15(31):1511-5.
37. Taillandier J, Ammar A, Rabourdin JP, Ribeyre JP, Pichon J, Niddam S, Pierart H. Treatment of cerebral aging disorders with Ginkgo biloba extract. A longitudinal multicenter double-blind drug vs. placebo study. Presse Med. 1986 Sep 25;15(31):1583-7.
38. Warburton DM. Clinical psychopharmacology of Ginkgo biloba extract. Presse Med. 1986 Sep25;15(31):1595-604.
39. Winter JC. The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and ongevity in the rat. Physiol Behav. 1998 Feb 1;63(3):425-33.
Üreticinin stoklarıyla sınırlıdır.
|
Sepetim
Detay göster
